“Molecular-binding energies computed by docking tool revealed the possible contribution towards pancreatic lipase inhibitory properties of secondary metabolites including myricetin , isomangiferin, icariside B4, kaempferol and luteolin derivatives when compared to the standard drug orlistat.”